Observational Study on Rectal Cancer to Verify if Response After Chemo-radiotherapy Can be Predicted With a Particular Blood Test. (LiBReCa)
A Proof-of-concept, Prospective, Observational Study to Investigate the Value of Liquid Biopsies to Predict Tumor Response After Neoadjuvant Chemo-radiotherapy in Patients With Locally Advanced Rectal Cancer: the LiBReCa Study
Sponsor: Clinical Trial Unit Ente Ospedaliero Cantonale
Terminated
failure to identify complete responders since ctDNA disappears after radiotherapy in most patients.
Other terminated trials from Clinical Trial Unit Ente Ospedaliero Cantonale
See all terminations from Clinical Trial Unit Ente Ospedaliero Cantonale
Other Locally Advanced Rectal Cancer trials with similar outcome
Listed as NCT03699410, this observational or N/A phase trial focuses on Locally Advanced Rectal Cancer and remains terminated or withdrawn. Sponsored by Clinical Trial Unit Ente Ospedaliero Cantonale, it has been updated 10 times since 2018, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Nov 2021 — Dec 2021 [monthly]
Terminated
Status: Unknown Status → Terminated
-
Oct 2021 — Nov 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2019 — Nov 2020 [monthly]
Recruiting
-
Feb 2019 — Sep 2019 [monthly]
Recruiting
-
Nov 2018 — Feb 2019 [monthly]
Recruiting
First recorded
Aug 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Clinical Trial Unit Ente Ospedaliero Cantonale
- Dimitri Christoforidis
For direct contact, visit the study record on ClinicalTrials.gov .